Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study
暂无分享,去创建一个
Tetsuji Sato | K. Yoneyama | T. Matsushita | K. Nogami | M. Taki | M. Shima | K. Fukutake | H. Hanabusa | Naoki Fukazawa | Shingo Maisawa